Norwegian national focal point

This report highlights the responses taken by the EMCDDA's Reitox network of national focal points to the COVID-19 crisis and describes the challenges met by the organisations and the strategies produced to overcome these challenges.

This report provides a comprehensive analysis of patterns emerging across Europe in the areas of drug supply, illicit drug use and associated public health problems. National data sets are also provided across these themes and on key harm-reduction interventions. The report is available in English...

This report, available in 24 languages, presents a summary of some the main findings of the 'European Drug Report 2020: Trends and Developments the EMCDDA’s latest analysis of the drug situation in Europe. The issues selected here have been chosen for their policy relevance and general interest.

Over the past quarter of a century, the EMCDDA has expanded its monitoring capability to keep pace with revolutionary changes in the extent and nature of the drugs problem and in the world in which we live. By complementing data routinely submitted by Member States with information from an...

Follow the timeline and take a walk through some of the key moments in the EMCDDA's 25 years of international cooperation.

This report presents the top-level overview of the drug phenomenon in Norway, covering drug supply, use and public health problems as well as drug policy and responses. The statistical data reported relate to 2017 (or most recent year) and are provided to the EMCDDA by the national focal point,...